Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A36182 | 18802068 | J Immunol | Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. | 2008 | Details |
A36185 | 18795699 | Hepatogastroenterology | Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis. | 2009 | Details |
A36201 | 18761681 | Hepatol Res | Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. | 2008 | Details |
A36214 | 18718471 | Gastroenterology | Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. | 2008 | Details |
A36237 | 18666257 | Hepatology | Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. | 2008 | Details |
A36238 | 18666236 | Hepatology | Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. | 2008 | Details |
A36253 | 18636507 | IUBMB Life | Thioredoxin and thioredoxin binding protein 2 in the liver. | 2008 | Details |
A36260 | 18609744 | J Rheumatol | Drug use and toxicity in psoriatic disease: focus on methotrexate. | 2008 | Details |
A36270 | 18571789 | Hepatology | Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. | 2008 | Details |
A36272 | 18563978 | Rev Esp Enferm Dig | [Gene expression in obese patients with non-alcoholic steatohepatitis]. | 2008 | Details |
A36291 | 18513333 | Hepatol Res | Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line. | 2008 | Details |
A36297 | 18503774 | Gastroenterology | Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. | 2008 | Details |
A36319 | 18467911 | Eur J Gastroenterol Hepatol | Bile acid levels are increased in the liver of patients with steatohepatitis. | 2008 | Details |
A36320 | 18465233 | Dig Dis Sci | Effects of a long-term high-fat diet and switching from a high-fat to low-fat, standard diet on hepatic fat accumulation in Sprague-Dawley rats. | 2008 | Details |
A36323 | 18459024 | Obes Surg | Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity. | 2008 | Details |
A36324 | 18458846 | J Gastroenterol | Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. | 2008 | Details |
A36341 | 18408102 | Gut | Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. | 2008 | Details |
A36343 | 18403495 | Gut | Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. | 2008 | Details |
A36348 | 18392239 | J Gastrointestin Liver Dis | Angiotensin II type 1 receptor antagonist improves the prognosis in rats displaying liver cirrhosis induced by a choline-deficient diet. | 2008 | Details |
A36384 | 18328071 | Hepatol Res | Prevalence of esophagogastric varices in patients with non-alcoholic steatohepatitis. | 2008 | Details |
A36404 | 18277895 | J Clin Gastroenterol | Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. | 2008 | Details |
A36413 | 18239988 | Wien Klin Wochenschr | Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful? | 2008 | Details |
A36428 | 18228197 | Histol Histopathol | Presence of perivenular elastic fibers in nonalcoholic steatohepatitis Fibrosis Stage III. | 2008 | Details |
A36431 | 18226970 | Surg Obes Relat Dis | Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? | 2008 | Details |
A36439 | 18197877 | Hepatol Res | Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. | 2008 | Details |
A36476 | 18049900 | Dig Dis Sci | Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol. | 2007 | Details |
A36482 | 18042441 | J Cyst Fibros | A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. | 2007 | Details |
A36487 | 18029322 | Adv Ther | Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection. | 2008 | Details |
A36492 | 18000880 | Hepatology | Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis. | 2008 | Details |
A36493 | 18000736 | Obes Surg | Effect of high fat diet on the volume of liver and quantitative feature of Kupffer cells in the female rat: a stereological and ultrastructural study. | 2007 | Details |
A36504 | 17973959 | Am J Transplant | Cystic fibrosis liver disease: to transplant or not to transplant? | 2007 | Details |
A36511 | 17963695 | Biochem Biophys Res Commun | Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. | 2007 | Details |
A36516 | 17947452 | Am J Physiol Gastrointest Liver Physiol | A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. | 2007 | Details |
A36534 | 17929294 | Hepatology | Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. | 2007 | Details |
A36543 | 17892356 | Expert Rev Mol Diagn | FibroMAX: towards a new universal biomarker of liver disease? | 2007 | Details |
A36551 | 17873605 | Eur J Gastroenterol Hepatol | Primary liver cancers with nonalcoholic steatohepatitis. | 2007 | Details |
A36562 | 17825453 | J Hepatol | Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. | 2007 | Details |
A36576 | 17710676 | Scand J Gastroenterol | Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. | 2007 | Details |
A36582 | 17690174 | Am J Physiol Gastrointest Liver Physiol | Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. | 2007 | Details |
A36584 | 17680648 | Hepatology | HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. | 2007 | Details |
A36598 | 17659580 | Hepatology | Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. | 2007 | Details |
A36600 | 17654603 | Hepatology | Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. | 2007 | Details |
A36606 | 17631134 | Gastroenterology | Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. | 2007 | Details |
A36613 | 17610504 | Hepatol Res | Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. | 2007 | Details |
A36614 | 17610502 | Hepatol Res | Combined pantethine and probucol therapy for Japanese patients with non-alcoholic steatohepatitis. | 2007 | Details |
A36634 | 17565640 | J Gastroenterol Hepatol | Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis. | 2007 | Details |
A36637 | 17559148 | Hepatology | The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. | 2007 | Details |
A36648 | 17530362 | J Gastroenterol | Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. | 2007 | Details |
A36654 | 17518368 | Hepatology | Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. | 2007 | Details |
A36672 | 17483780 | Gastroenterol Clin Biol | [Steatosis, chronic hepatitis virus C infection and homocysteine]. | 2007 | Details |
A36688 | 17459514 | J Hepatol | Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. | 2007 | Details |
A36702 | 17429733 | Dig Dis Sci | The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis. | 2007 | Details |
A36704 | 17420940 | Dig Dis Sci | Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. | 2007 | Details |
A36707 | 17415655 | Dig Dis Sci | Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet. | 2007 | Details |
A36710 | 17410441 | Dig Dis Sci | Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats. | 2007 | Details |
A36711 | 17410287 | J Gastrointestin Liver Dis | Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. | 2007 | Details |
A36714 | 17404856 | Dig Dis Sci | Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH). | 2007 | Details |
A36722 | 17388862 | Intern Med J | Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. | 2007 | Details |
A36723 | 17385458 | Ter Arkh | [Outpatient clinic facilities for clinical-laboratory diagnosis of hepatic fibrosis]. | 2007 | Details |
A36726 | 17379003 | Metabolism | Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis. | 2007 | Details |
A36742 | 17355768 | Obes Surg | Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery. | 2007 | Details |
A36745 | 17351431 | Invest Radiol | Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. | 2007 | Details |
A36751 | 17335677 | Curr Gastroenterol Rep | Treatment of fibrosis in nonalcoholic fatty liver disease. | 2007 | Details |
A36760 | 17322381 | Am J Pathol | Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. | 2007 | Details |
A36766 | 17311617 | Liver Int | Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis. | 2007 | Details |
A36799 | 17244458 | Zhonghua Gan Zang Bing Za Zhi | [The role of apoptosis and the related genes in non-alcoholic steatohepatitis]. | 2007 | Details |
A36801 | 17241878 | Gastroenterology | Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. | 2006 | Details |
A36805 | 17229244 | Aliment Pharmacol Ther | Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia. | 2007 | Details |
A36808 | 17217634 | Obes Surg | Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. | 2006 | Details |
A36836 | 17137680 | Rev Med Interne | [Results and place of Fibroscan in the non-invasive diagnosis of hepatic fibrosis]. | 2006 | Details |
A36841 | 17128639 | Postgrad Med | Noninvasive tests for liver fibrosis. | 2006 | Details |
A36848 | 17105586 | Liver Int | Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. | 2006 | Details |
A36850 | 17101320 | Gastroenterology | Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. | 2006 | Details |
A36851 | 17086867 | Hepatogastroenterology | Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH). | 2007 | Details |
A36860 | 17060319 | J Biol Chem | Impaired proteolysis of collagen I inhibits proliferation of hepatic stellate cells: implications for regulation of liver fibrosis. | 2006 | Details |
A36872 | 17032406 | Liver Int | Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis. | 2006 | Details |
A36886 | 17006938 | Hepatology | Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. | 2006 | Details |
A36893 | 16988759 | J Gastroenterol | Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature. | 2006 | Details |
A36911 | 16958001 | Dig Dis Sci | Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitis. | 2006 | Details |
A36912 | 16953841 | Liver Int | Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis. | 2006 | Details |
A36925 | 16936261 | Am J Pathol | A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. | 2006 | Details |
A36948 | 16890173 | Hepatol Res | Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis. | 2005 | Details |
A36955 | 16868265 | Psychosom Med | Depression, anxiety, and nonalcoholic steatohepatitis. | 2008 | Details |
A36959 | 16848812 | Am J Gastroenterol | Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. | 2006 | Details |
A36963 | 16837098 | J Hepatol | Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. | 2006 | Details |
A36967 | 16814613 | Clin Gastroenterol Hepatol | Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement. | 2006 | Details |
A36987 | 16768127 | Nihon Rinsho | [NASH in children]. | 2006 | Details |
A36988 | 16768126 | Nihon Rinsho | [NASH and metabolic syndrome]. | 2006 | Details |
A36989 | 16768125 | Nihon Rinsho | [Insulin sensitizer--anti-diabetic drugs, metformin and pioglitazone that can improve insulin resistance]. | 2006 | Details |
A36990 | 16768123 | Nihon Rinsho | [Drug therapy for non-alcoholic steatohepatitis]. | 2006 | Details |
A36991 | 16768117 | Nihon Rinsho | [Non-alcoholic steatohepatitis : pathology and pathogenesis]. | 2006 | Details |
A36992 | 16768116 | Nihon Rinsho | [Drug-induced NASH]. | 2006 | Details |
A36995 | 16768113 | Nihon Rinsho | [Adipokine interrelationship with the liver]. | 2006 | Details |
A37058 | 16554999 | Surg Today | Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases. | 2006 | Details |
A37061 | 16546742 | Nan Fang Yi Ke Da Xue Xue Bao | [Nonalcoholic steatohepatitis: a clinicopathological analysis of liver biopsy in 32 cases]. | 2006 | Details |
A37062 | 16540767 | J Clin Gastroenterol | Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. | 2006 | Details |
A37068 | 16531962 | Ann Hepatol | Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. | 2006 | Details |
A37081 | 16672825 | J Clin Gastroenterol | Bariatric Surgery: A Promising Solution for Nonalcoholic Steatohepatitis in the Very Obese. | 2006 | Details |
A37091 | 16498637 | J Biochem Mol Toxicol | Glutathione-enhancing agents protect against steatohepatitis in a dietary model. | 2006 | Details |
A37093 | 16492691 | J Clin Endocrinol Metab | Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. | 2006 | Details |